Cigna Q2 Earnings Beat Estimates on Higher Specialty Volumes
CI's Q2 earnings benefit from strong Evernorth Health Services unit, offsetting customer losses and rising costs. It continues to expect 2025 adjusted EPS at a minimum of $29.60.
Cigna to Report Q2 Earnings: Can Evernorth Offset Healthcare Weakness?
CI's Q2 results are likely to hinge on Evernorth's growth as core healthcare revenues and premiums face steep declines.
Can Optum Support UnitedHealth's Profit Amid Industry Headwinds?
UNH leans on Optum's diversified growth and value-based care to counter insurance sector margin pressure in Q2.
Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare - And Trade Deal Optimism Boosts Markets Bulls And Bears: T-Mobile, LendingTree, Molina Healthcare - And Trade Deal Optimism Boosts Markets - Cigna Group ( NYSE:CI ) , C3.ai ( NYSE:AI )
Benzinga examined the prospects for many investors' favorite stocks over the last week - here's a look at some of our top stories. Wall Street rallied as a wave of new trade deals - including agreements with Japan, Indonesia, and the Philippines - fueled optimism, pushing the S&P 500 and Nasdaq ...
Molina Healthcare Stumbles; Cigna, CVS And Humana Go With It - Molina Healthcare ( NYSE:MOH )
Molina reported Q2 EPS of $5.48, below estimates of $6.21; revenue beat at $11.43 billion vs. $10.93 billion. Molina cut 2025 EPS outlook to over $19, down from $21.50-$22.50; MCR forecast at 90.2% Up Next: Get 5 Dark Horse Stocks Wall Street Is Quietly Loading Up On Molina Healthcare Inc.
What's Shaping CVS' Health Care Benefits Arm for the Rest of 2025?
CVS Health's Health Care Benefits arm posts solid Medicare gains and prepares for an ACA exit with a $448M reserve.
UnitedHealth's Commercial Unit: A Stabilizer Amid Healthcare Turmoil?
UNH relies on its growing commercial insurance business as pressures from Medicare mount and industry headwinds persist.
UnitedHealth vs. Cigna: Which Insurer to Buy Amid Sector Turmoil?
CI's commercial focus and clearer outlook set it apart as UNH faces guidance pulls, CEO change and rising medical costs.
UnitedHealth, Centene Hit Hard By Guidance Shock, Trump's Medicaid Push - Humana ( NYSE:HUM ) , Cigna Group ( NYSE:CI ) , Centene ( NYSE:CNC ) , Progressive ( NYSE:PGR )
UnitedHealth's market cap plunged 40.9% in Q2, but it remains the largest U.S. insurer at $283 billion. Centene shares crashed 40.37% on July 2 after it pulled 2025 guidance, sparking sector-wide declines. Get daily-updated rankings across momentum, growth, value, trends, and quality to spot the ...
Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment
CI to cover RhinAer for chronic rhinitis starting Sept. 15, expanding access to a minimally invasive, office-based treatment.
Zacks Industry Outlook Highlights Cigna, Humana, Centene and Molina Healthcare
CNC, MOH, CI, and HUM are set to benefit from Medicare demand, steady premiums, and tech-driven growth in the HMO space.
4 HMO Stocks Set to Thrive From Steady Premium Flows, M&A Strategy
Rising premiums, ongoing technological innovation and the growing demand for Medicare plans are anticipated to propel the performance of the Zacks Medical-HMO industry players. CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
Exploring CVS' Health Services Segment: A Key Growth Engine for 2025?
CVS' Health Services segment posts $43B in revenues as specialty pharmacy and Caremark deals drive 2025 growth prospects.
Here's Why You Should Hold Cigna Stock in Your Portfolio for Now
CI gains 14.7% YTD as Evernorth and Cigna Healthcare drive growth, but rising expenses and debt pose challenges.
CVS or Cigna: Which Diversified Healthcare Stock Should You Own Now?
CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare strategy.
The Zacks Analyst Blog Highlights Costco Wholesale, Chubb, Cigna, Global Self Storage and Natural Health Trends
Costco eyes 11.3% EPS growth in 2025, Chubb boosts income outlook, and Cigna posts strong Q1 as Zacks spotlights five standout stocks.
CI's Unit Unveils Offering to Expand Access to GLP-1 Medications
Cigna's Evernorth business caps GLP-1 drug copays at $200 or less, aiming to boost affordability for patients and cut costs for health plan sponsors.
Trump Again Promises Lower Drug Prices By 'Cutting Out Middlemen' Like UnitedHealth, CVS: Will It Work This Time? - UnitedHealth Group ( NYSE:UNH )
Drug manufacturers have 30 days to voluntarily lower prices for prescription drugs in the U.S., Trump says. Trump tried this in 2020 but the courts blocked the order; Sanders fears the same thing might happen again. Get our list of 10 overlooked stocks-including one paying a 9% dividend-before ...
Trump Orders US Drug Prices To Match Abroad: Will It Work? - UnitedHealth Group ( NYSE:UNH )
Drug manufacturers have 30 days to voluntarily lower prices for prescription drugs in the U.S., Trump says. Trump tried this in 2020 but the courts blocked the order; Sanders fears the same thing might happen again. Get our list of 10 overlooked stocks-including one paying a 9% dividend-before ...
CVS Health, Cigna Stocks Dip Tuesday: What's Going On? - CVS Health ( NYSE:CVS ) , Cigna Group ( NYSE:CI )
The order essentially aims to tie U.S. drug prices to those paid by other countries. Get Matt Maley's top trade setups for a tariff-driven market, live this Wednesday at 6 PM ET. Reserve your free spot now. CVS Health Corporation CVS and The Cigna Group CI shares trading lower Tuesday.
Neuronetics Reports First Quarter 2025 Financial and Operating Results
MALVERN, Pa., May 06, 2025 ( GLOBE NEWSWIRE ) -- Neuronetics, Inc., ( NASDAQ: STIM ) ( the "Company" or "Neuronetics" ) a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they ...
Cigna Q1 Earnings Beat Estimates on Evernorth Health Strength
CI increases adjusted earnings guidance for 2025 to $29.60 per share from the previous estimate of $29.50.
Cigna CEO Says Strong Q1 Earnings, Increased Outlook Reflect Strength In Growth Platforms - Cigna Group ( NYSE:CI )
Q1 revenue rose 14% to $65.45B, beating estimates; adjusted EPS of $6.74 topped $6.35 forecast. Evernorth sales hit $53.68 billion, up 16%, with specialty services up 19% and pharmacy benefit services up 14%.
US Futures Rise As Apple, Amazon, Airbnb Earnings Boost Market Sentiment: S&P 500 Hits Milestone That's Preceded A 100% Win Rate Since 1956, Says Expert - Apple ( NASDAQ:AAPL ) , Airbnb ( NASDAQ:ABNB )
U.S. stock futures are in the green early Friday, after another winning day for the markets in the regular session on Thursday. What Happened: The futures markets continue to inch higher following fresh signals from China that it is open to begin trade negotiations with Washington after weeks of ...
Cigna Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Cigna Group ( NYSE:CI )
The Cigna Group CI will release earnings results for the first quarter, before the opening bell on Friday, May 2. Analysts expect the Bloomfield, Connecticut-based company to report quarterly earnings at $6.35 per share, down from $6.47 per share in the year-ago period.
Will Declining Medical Customers Affect Cigna's Q1 Earnings?
CI's first-quarter results are likely to have benefited from growing pharmacy revenues and fees.
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
Policy update increases access for millions covered by Evernorth Health Services Policy update increases access for millions covered by Evernorth Health Services ...
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
MALVERN, Pa., March 31, 2025 ( GLOBE NEWSWIRE ) -- Neuronetics, Inc. ( NASDAQ: STIM ) , a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading ...
Elevance Trades at a Bargain: Is it a Good Time to Buy ELV Stock?
With a strengthening commercial business, ELV is seeing steady membership growth.
The Joint Gears Up for Q4 Earnings: Here's What to Expect
JYNT's fourth-quarter results are likely to reflect higher Royalty fees, Software fees and Advertising fund revenues.
Acadia Healthcare Q4 Earnings Miss on Reduced Length of Stay
ACHC expects revenues to be between $3.3 billion and $3.4 billion in 2025.
Teladoc Health Q4 Loss Widens on Soft Integrated Care Unit
TDOC expects revenues in the Integrated Care segment to witness 0-3% growth on a year-over-year basis.
Universal Health Q4 Earnings Beat on Strong Adjusted Admissions
UHS' fourth-quarter earnings benefit from rising admissions and patient days. Higher expenses partially offset the positives.
Healthcare Stocks Decline After Trump Signs Executive Order On Price Transparency - Cigna ( NYSE:CI )
Healthcare stocks decline following Trump's executive order enforcing stricter healthcare price transparency regulations. Price transparency enforcement could impact healthcare companies' financials, with potential for lower negotiated rates.
Acadia Healthcare to Report Q4 Earnings: Can it Overcome Rising Costs?
ACHC's fourth-quarter earnings are likely to have benefited from growing patient days and admissions.
Universal Health to Report Q4 Earnings: What Do the Estimates Say?
UHS' fourth-quarter earnings are likely to have benefited from growing admissions and patient days.
Select Medical Q4 Earnings Miss Estimates, Stock Down 7.2%
SEM expects revenues to be between $5.4 billion and $5.6 billion, the mid-point of which implies 5.8% growth from the 2024 figure of $5.2 billion.
Community Health Q4 Earnings Miss on Lower Adjusted Admissions
CYH expects 2025 capital expenditures to be in the range of $350-$4000 million.
Pediatrix Medical Gears Up for Q4 Results: What to Expect?
MD's fourth-quarter results are likely to reflect declining revenues and expenses.
Can Community Health Beat Q4 Earnings on Growing Occupancy?
CYH's fourth-quarter earnings are likely to have been aided by higher revenue per adjusted admission.
Can Tenet Healthcare Navigate Through Lower Revenues in Q4?
THC's fourth-quarter results are likely to reflect growing patient admissions, utilization and patient days.
Company News for Jan 31, 2025
Companies in The News Are: ...
Cigna Group ( CI ) Q4 2024 Earnings Call Transcript
CI earnings call for the period ending December 31, 2024.
Cigna Q4 Earnings Miss Estimates on Decline in Medical Membership
CI's Q4 results reflect a decline in Individual and Family Plans customers. Management expects 2025 adjusted EPS at a minimum of $29.50, which indicates growth of at least 7.9% from the 2024 figure.
Cigna Stock Dives On Q4 Earnings Miss: 'We Are Taking Corrective Actions To Address These Near-Term Pressures' - Cigna ( NYSE:CI )
Cigna reports fourth-quarter revenue of $65.68 billion, beating analyst estimates of $63.36 billion. Cigna reports fourth-quarter adjusted earnings of $6.64 per share, missing analyst estimates of $7.82 per share. Get Wall Street's Hottest Chart Every Morning
UPS, Whirlpool, Microsoft And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Microsoft ( NASDAQ:MSFT ) , Cigna ( NYSE:CI )
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 50 points on Thursday. Shares of United Parcel Service, Inc. UPS fell sharply in today's pre-market trading after the company missed fourth-quarter revenue expectations despite beating EPS estimates.
Rising Medical Costs to Affect Cigna Q4 Earnings? Check Estimates Here
CI's fourth-quarter results are likely to have benefited from growing premiums and pharmacy revenues.
Elevance Health Q4 Countdown: Smart Move to Buy or Stick With Hold?
ELV's fourth-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.
FTC Report Reveals PBM Practices Impacting Competition and Drug Costs
The report comes at a time when insurers are grappling with rising medical costs.
Cigna Stock Plunges 18.7% in 3 Months: Should You Buy, Hold or Sell?
Despite market challenges, CI's strong fundamentals and growth drivers make it worth holding for long-term investors looking to capitalize on future recovery opportunities.
